NTIC (NTIC) Q3 2026: Xeros Oil & Gas Sales Surge 72% as Margin Recovery Signals Q4 Rebound
NTIC delivered record sales in Q3 2026, propelled by a 72% increase in Xeros oil and gas revenue, but gross margin was pressured by a sharp spike in raw material costs tied to Middle East shipping disruptions. Management expects these headwinds to abate in Q4, with pricing actions and operational discipline positioned to restore profitability momentum. Investors should focus on the company’s expanding high-margin segments and joint venture pipeline as cost normalization and targeted growth initiatives set the stage for stronger cash generation ahead.
Summary
- Xeros Oil & Gas Expansion: Oil and gas segment adoption and global contracts are reshaping NTIC’s margin profile.
- Margin Restoration in Focus: Pricing and procurement actions are positioned to offset recent raw material shocks.
- Growth Levers for Fiscal 2027: Joint venture rebound and new bioplastics applications underpin a stronger outlook.
Business Overview
NTIC, or Northern Technologies International Corporation, develops and markets advanced corrosion prevention and specialty bioplastic solutions. The company generates revenue through three primary segments: Xeros, its corrosion prevention business serving industrial and oil and gas markets; NatureTech, its bioplastics division offering compostable packaging and materials; and a global network of joint ventures, especially active in Europe, Asia, and the Americas. Its business model blends direct sales, joint venture equity income, and technology licensing, with an increasing focus on high-margin, application-driven solutions.
Performance Analysis
NTIC achieved a new record in consolidated net sales, up 12.6% year-over-year to $24.2 million, driven by standout 72.3% growth in Xeros oil and gas sales and solid gains across industrial and bioplastics. However, gross margin contracted by 477 basis points due to a spike in raw material costs, notably polyethylene, triggered by Middle East shipping disruptions. This margin squeeze resulted in a net loss for the quarter, a reversal from modest profitability a year ago.
Operating expenses rose 5.3% but were outpaced by revenue growth, reflecting disciplined cost control. Joint venture sales climbed 15.1%, with operating income from JVs up 12.2%, highlighting the network’s role as a stabilizing cash and earnings contributor. Notably, NTIC China maintained stable sales despite macro volatility, and trailing 12-month sales in China rose 12.8%, underscoring the region’s strategic importance for both industrial and bioplastics expansion.
- Oil and Gas Leverage: Xeros oil and gas sales have now surpassed $10 million on a trailing 12-month basis, marking a structural shift in segment mix.
- Bioplastics Volume Growth: NatureTech’s revenue grew 5%, but volume growth was closer to 10-12%, indicating price concessions amid competitive pressure.
- JV Contribution Resilience: Joint ventures delivered double-digit sales and income growth, especially in recovering European markets.
While Q3 margin erosion was acute, management expects sequential improvement as raw material costs normalize and pricing/cost actions take effect. The operational focus now turns to converting record sales into sustained bottom-line gains.
Executive Commentary
"Strong global demand and increasing adoptions of our Xeros corrosion prevention and NatureTech bioplastic solutions drove quarterly consolidated sales to new record highs. Disruptions to shipping through the Strait of Hormuz during the quarter caused by recent increased conflict levels in the Middle East contributed to a significant increase in our raw material costs. Higher input costs reduced our gross margin by approximately 477 basis points year over year, and we estimate that gross profit was negatively affected by approximately $1 million based on gross margin levels prior to the increase in U.S.-Iran hostilities. We believe that the third quarter cost pressure was temporary, and we are pursuing pricing and procurement initiatives that we expect will improve gross margin and profitability in the fourth quarter."
Patrick Lynch, CEO
"We expect quarterly sales to grow faster than operating expenses as we continue to leverage recent investments and upgrades across our global operations. Gross margin for the third quarter was impacted primarily by higher raw material costs as a result of the conflict in the Middle East and disruption of shipping through the Straits of Hormuz. We expect gross margin to improve sequentially for the fourth quarter of fiscal 2026."
Matt Wolsfeld, CFO
Strategic Positioning
1. Oil & Gas Segment Scaling
Xeros oil and gas, corrosion protection for energy infrastructure, has become NTIC’s highest growth engine, with sales up 72% and a robust pipeline spanning North America, Middle East, India, and Brazil. The business benefits from higher gross margins than legacy segments and is supported by long-term contracts such as a multi-year, $14 million-plus FPSO (floating production storage and offloading) project in Brazil. Management emphasizes continued investments in sales infrastructure and expects further profitability uplift as new projects ramp.
2. NatureTech Bioplastics Expansion
NatureTech, compostable bioplastics for packaging and industrial applications, continues to diversify its end-markets through innovation partnerships, including Bayer in India for biodegradable seedling cups and selection by the International Fresh Produce Association’s Packaging Innovation Program in North America. While commodity products face margin pressure from pricing competition, proprietary resin applications offer a path to healthier margins and global scale, with pilot commercialization expected within a year.
3. Joint Venture Network as a Growth and Stability Lever
NTIC’s global joint venture network, particularly in Europe and Asia, underpins both revenue growth and capital flexibility. Recent stabilization in Germany and anticipated economic stimulus-driven recoveries are expected to flow through to JV income, while the network also provides a buffer against regional volatility. The company holds $30.4 million in JV investments, with over half in cash, supporting liquidity and future reinvestment opportunities.
4. Cost Structure and Margin Restoration
Cost discipline is central to NTIC’s near-term strategy, with operating expenses now capped and management targeting revenue-driven margin expansion. The company is executing pricing actions and procurement initiatives to pass through cost increases and diversify sourcing. The sale of the Beachwood, Ohio facility will further streamline the footprint and release over $1 million in cash for redeployment.
5. Digital and AI-Driven Operational Efficiency
NTIC’s recent SAP implementation, coupled with external AI tools, is unlocking granular insights into customer and product-level profitability. This data-driven approach enables targeted pricing, supply chain agility, and improved working capital management, positioning the company to react quickly to market changes and optimize margin capture as volumes scale.
Key Considerations
NTIC’s Q3 underscores a business at a strategic inflection, balancing near-term margin volatility with accelerating adoption in high-value segments and operational upgrades. Investors should weigh the following:
Key Considerations:
- Raw Material Cost Sensitivity: Margin volatility from global supply chain shocks remains a key variable, but recent price normalization and pricing actions are expected to restore profitability.
- Segment Mix Shift: The rapid scaling of Xeros oil and gas, with structurally higher margins, is changing NTIC’s earnings power and risk profile.
- Bioplastics Innovation Cycle: NatureTech’s growth hinges on successful commercialization of proprietary applications, with volume gains partly offset by price concessions in commodity products.
- JV Network Leverage: Joint ventures provide both cash flow stability and optionality for future growth, especially as European markets recover.
- Cost Control Discipline: Operating expenses are now flat, with no major new investments planned at the corporate level, focusing future margin expansion on topline leverage.
Risks
NTIC remains exposed to global macro disruptions, especially in raw material pricing, as seen in Q3’s margin shock from Middle East conflict. Competitive pricing in commodity bioplastics and execution risk in scaling new applications could pressure profitability if not offset by mix and volume gains. The company’s reliance on joint ventures and international markets introduces currency and geopolitical risk, while the pace of cost normalization and demand recovery in key regions will determine the trajectory of margin restoration.
Forward Outlook
For Q4 2026, NTIC guided to:
- Sequential gross margin improvement as raw material costs recede and pricing actions flow through.
- Higher consolidated revenue, with Xeros oil and gas and NatureTech expected to drive growth.
For full-year 2026, management maintained a constructive outlook:
- Improved profitability and cash generation, supported by disciplined expense management and margin recovery.
Management highlighted several factors that will shape the outlook:
- Backlog strength and invoicing in oil and gas, with Q4 set to be the strongest quarter of the year.
- Continued expansion in high-margin applications and JV markets as stimulus and infrastructure rebuilds gain traction.
Takeaways
NTIC’s Q3 2026 marks a pivotal transition, with record sales and segment mix shift offsetting temporary margin shocks. The company’s ability to convert topline gains into sustainable profitability will be the key watchpoint for investors as the year closes.
- Oil & Gas Outperformance: Xeros oil and gas is now the company’s primary growth and margin lever, with global contracts and high adoption rates.
- Margin Recovery Path: Raw material normalization and pricing discipline are expected to restore profitability, with cost actions already underway.
- Innovation and JV Leverage: NatureTech’s pipeline and JV network provide optionality for future growth, but execution in commercialization will determine long-term upside.
Conclusion
NTIC’s Q3 results reflect a business navigating near-term margin headwinds while positioning for higher quality growth. The focus on high-margin segments, pricing actions, and operational discipline sets the stage for a stronger Q4 and improved cash generation in fiscal 2027.
Industry Read-Through
NTIC’s experience this quarter is emblematic of broader industrial and specialty materials trends: raw material volatility remains a central risk for manufacturers, especially those with global supply chains exposed to geopolitical shocks. The company’s proactive pricing and procurement response, along with digital transformation and AI-driven analytics, signal a playbook for peers facing similar challenges. Bioplastics innovation and adoption cycles are lengthening, with volume growth offset by price competition—a dynamic relevant for all players in sustainable packaging. Finally, the importance of joint venture networks and diversified geographic exposure is reinforced as a buffer against regional volatility and a lever for growth as stimulus and infrastructure spending accelerate in Europe and Asia.